fda glp-1 compounding crackdown news october 2025 cracks down on 'misleading' compounded GLP-1s by telehealth companies - Indianapolis | Indiana Weather | Indiana Traffic Compounders maintain a firm grip

Further analysis revealed evidence of an increasing age- and sex-standardized incidence of new GLP-1 receptor agonist use during the study period, with a notable increase after 2020

Two oral GLP-1s have now received FDA approval: Novo Nordisks WEGOVY pill (December 2025) and Eli Lillys FOUNDAYO (April 2026)

Pernicious anaemia is more common in older women, and it is not rare

Consequently, pure alcohol and ether solvents may be used for spectroscopic studies

Balance doesnt happen overnight, but with consistency and intention, your body becomes stronger, more resilient, and more in sync

However, its worth noting that the abundance of exclusively positive reviews on the website may raise questions about their authenticity